4//SEC Filing
Bisker-Leib Vered 4
Accession 0001493152-23-002243
CIK 0001100397other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:17 PM ET
Size
10.7 KB
Accession
0001493152-23-002243
Insider Transaction Report
Form 4
Bisker-Leib Vered
Director
Transactions
- Award
Stock Option
2023-01-19+1,171→ 1,171 totalExercise: $55.23Exp: 2031-06-09→ Common Stock (1,171 underlying) - Award
Stock Option
2023-01-19+1,171→ 1,171 totalExercise: $8.69Exp: 2032-06-12→ Common Stock (1,171 underlying) - Award
Stock Option
2023-01-19+1,639→ 1,639 totalExercise: $58.59Exp: 2030-08-17→ Common Stock (1,639 underlying)
Footnotes (6)
- [F1]The option vests and becomes exercisable in thirty-six substantially equal monthly installments, such that the option shall be fully vested on August 18, 2023.
- [F2]Received in the merger of Ayala Pharmaceuticals, Inc. ("Old Ayala") into the Issuer (the "Merger") in exchange for an employee stock option to acquire 8,750 shares of the common stock of Old Ayala for $10.98 per share.
- [F3]This option is fully vested and exercisable.
- [F4]Received in the Merger in exchange for an employee stock option to acquire 6,250 shares of the common stock of Old Ayala for $10.35 per share.
- [F5]This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
- [F6]Received in the Merger in exchange for an employee stock option to acquire 6,250 shares of the common stock of Old Ayala for $1.63 per share.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001100397
Entity typeother
Related Parties
1- filerCIK 0001814093
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:17 PM ET
- Size
- 10.7 KB